Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.

Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R, Gladstone H, Chang HY, Morganroth GS, Oro AE, Brown PO.

Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14842-7. Epub 2006 Sep 26.

2.

Bone morphogenetic proteins.

Chen D, Zhao M, Mundy GR.

Growth Factors. 2004 Dec;22(4):233-41. Review.

PMID:
15621726
3.

Bone morphogenetic proteins and their antagonists: current and emerging clinical uses.

Ali IH, Brazil DP.

Br J Pharmacol. 2014 Aug;171(15):3620-32. doi: 10.1111/bph.12724. Review.

4.

BMP signaling and its paradoxical effects in tumorigenesis and dissemination.

Zhang L, Ye Y, Long X, Xiao P, Ren X, Yu J.

Oncotarget. 2016 Nov 22;7(47):78206-78218. doi: 10.18632/oncotarget.12151. Review.

5.

Bone morphogenetic protein-2 and tumor growth: Diverse effects and possibilities for therapy.

Tian H, Zhao J, Brochmann EJ, Wang JC, Murray SS.

Cytokine Growth Factor Rev. 2017 Apr;34:73-91. doi: 10.1016/j.cytogfr.2017.01.002. Epub 2017 Jan 12. Review.

PMID:
28109670

Supplemental Content

Support Center